Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The peptide does not suppress natural hormone production, cause organ toxicity at therapeutic doses, or produce withdrawal effects upon discontinuation
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
SLU-PP-332 (500mcg) / 5-Amino-1MQ (50mg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 90 Tablets Oral solid-form research compound formulated for controlled analytical and investigational applications
Increased energy is often the first noticeable change, followed by gradual improvements in body composition over subsequent weeks
US$ 20.45
US$ 23.70
US$ 28.02
US$ 25.80
